Skip to main content

Table 1 Clinical and laboratory characteristics

From: Monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention

Parameters Total(N = 673)
Age (years) 59.1 ± 10.8
Male sex [n (%)] 543(80.7)
Smoking [n (%)] 315(46.8)
Alcohol intake[n (%)] 251(37.3)
Hypertension [n (%)] 323(48.0)
Family history of CAD [n (%)] 145(21.5)
Hypercholesterolemia [n (%)] 287(42.6)
Diabetes [n (%)] 170(25.3)
LVEF (%) 61 ± 7
Regular drug taking[n (%)] 594(88.3)
Pre-procedural laboratory parameters
 SBP (mmHg) 134 ± 26
 HR (bpm) 75 ± 10
 WBC (× 109/L) 7.49 ± 2.33
 Monocyte (× 109/L) 0.52 ± 0.22
 TG(mmol/l) 1.61(1.18–2.48)
 TC(mmol/l) 4.04 ± 1.21
 LDL-C(mmol/l) 1.32(1.06–2.22)
 HDL-C(mmol/l) 1.48(0.93–2.48)
 Gensini score 36(20–64)
 MHR 0.40 ± 0.30
MHR quartiles
 Q1(≤0.19) 167(24.8)
 Q2(0.19–0.33) 177(26.3)
 Q3(0.33–0.53) 158(23.5)
 Q4(> 0.53) 171(25.4)
 Follow-up time (months) 39 ± 25
  1. WBC White blood cell, SBP Systolic blood pressure, HR Heart ratio, TG Triglyceride, TC Cholesterol, HDL-C High-density lipoprotein cholesterol, LDL-C Low-density lipoprotein cholesterol, LVEF Left ventricular ejection fraction; Regular drug taking: angiotensin-converting enzyme inhibitor, angiotensin II receptor blocker and statin were administered by medical advice, MHR Monocyte/HDL-C ratio